Income Statement Novartis AG

Equities

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 11:30:57 2025-12-05 EST			5-day change	1st Jan Change
107.08 ^CHF	+0.19%		+2.49%	+20.72%

12-05	Novartis raises guidance and target price after strong execution
12-04	Lupin Gets Tentative U.S. FDA Nod for Siponimod Tablets	MT

0e5ee.hKyQWeuRJt6vMoT01xCNLzvsHSKWP3O8sZizOa8bp_c.0pjBDaTOXLb-WLyY7l7iS3itUXjiVkvrwNbsdJou8bnPnNoLm9ts7sZ9yQ

Published financial data: NOVARTIS AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	48.66B	51.63B	50.54B	45.44B	50.32B
Other Revenues, Total	1.24B	1.25B	1.28B	1.22B	1.4B
Total Revenues	49.9B	52.88B	51.83B	46.66B	51.72B
Cost of Goods Sold, Total	14.4B	15.44B	15.08B	12.02B	12.82B
Gross Profit	35.5B	37.44B	36.74B	34.64B	38.91B
Selling General & Admin Expenses, Total	14.09B	14.82B	14.19B	12.49B	12.56B
R&D Expenses	8.55B	9.15B	9.25B	9.01B	9.51B
Other Operating Expenses	670M	653M	449M	498M	512M
Other Operating Expenses, Total	23.31B	24.62B	23.88B	22B	22.59B
Operating Income	12.19B	12.82B	12.86B	12.64B	16.32B
Interest Expense, Total	-869M	-811M	-837M	-855M	-1.01B
Interest And Investment Income	91M	71M	379M	627M	568M
Net Interest Expenses	-778M	-740M	-458M	-228M	-438M
Income (Loss) On Equity Invest.	673M	15.34B	-9M	-13M	-38M
Currency Exchange Gains (Loss)	-135M	-69M	-184M	-214M	-258M
Other Non Operating Income (Expenses)	-29M	-153M	-54M	3M	61M
EBT, Excl. Unusual Items	11.92B	27.2B	12.15B	12.19B	15.65B
Restructuring Charges	-	-	-	-951M	-364M
Merger & Related Restructuring Charges	-89M	-	-	-	-
Gain (Loss) On Sale Of Investments	336M	38M	-260M	-105M	-45M
Gain (Loss) On Sale Of Assets	414M	728M	166M	225M	45M
Asset Writedown	-1.34B	-653M	-1.69B	-3.09B	-1.43B
Legal Settlements	-935M	-212M	-369M	542M	-89M
Other Unusual Items	-431M	-965M	-1.63B	310M	-126M
EBT, Incl. Unusual Items	9.88B	26.14B	8.37B	9.12B	13.64B
Income Tax Expense	1.81B	2.12B	1.42B	551M	1.7B
Earnings From Continuing Operations	8.07B	24.02B	6.96B	8.57B	11.94B
Earnings Of Discontinued Operations	-	-	-	6.28B	-
Net Income to Company	8.07B	24.02B	6.96B	14.85B	11.94B
Minority Interest	1M	3M	-	-4M	2M
Net Income - (IS)	8.07B	24.02B	6.96B	14.85B	11.94B
Net Income to Common Incl Extra Items	8.07B	24.02B	6.96B	14.85B	11.94B
Net Income to Common Excl. Extra Items	8.07B	24.02B	6.96B	8.57B	11.94B
Per Share Items
Net EPS - Basic	3.54	10.71	3.19	7.15	5.92
Basic EPS - Continuing Operations	3.54	10.71	3.19	4.13	5.92
Basic Weighted Average Shares Outstanding	2.28B	2.24B	2.18B	2.08B	2.02B
Net EPS - Diluted	3.52	10.63	3.17	7.1	5.87
Diluted EPS - Continuing Operations	3.52	10.63	3.17	4.1	5.87
Diluted Weighted Average Shares Outstanding	2.3B	2.26B	2.2B	2.09B	2.04B
Normalized Basic EPS	3.27	7.58	3.48	3.67	4.85
Normalized Diluted EPS	3.24	7.52	3.46	3.64	4.81
Dividend Per Share	3.4	3.39	3.46	3.92	3.86
Payout Ratio	86.56	30.67	107.92	48.86	63.85
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	17.41B	17.94B	18B	17.52B	20.66B
EBITA	15.65B	16.73B	16.84B	16.6B	19.78B
EBIT	12.19B	12.82B	12.86B	12.64B	16.32B
EBITDAR	17.42B	17.95B	18.01B	17.53B	20.67B
Effective Tax Rate - (Ratio)	18.29	8.11	16.92	6.04	12.47
Current Domestic Taxes	932M	958M	617M	1.14B	897M
Current Foreign Taxes	1.17B	1.47B	1.45B	1.29B	1.49B
Total Current Taxes	2.1B	2.43B	2.07B	2.43B	2.38B
Deferred Domestic Taxes	137M	-23M	142M	-355M	245M
Deferred Foreign Taxes	-430M	-286M	-797M	-1.52B	-927M
Total Deferred Taxes	-293M	-309M	-655M	-1.88B	-682M
Normalized Net Income	7.45B	17B	7.6B	7.61B	9.78B
Interest Capitalized	2M	4M	5M	3M	5M
Interest on Long-Term Debt	67M	62M	60M	62M	72M
Supplemental Operating Expense Items
Selling and Marketing Expenses	-	-	-	-	-
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	9.02B	9.54B	10B	11.37B	10.02B
Net Rental Expense, Total	11M	13M	9M	11M	12M
Imputed Operating Lease Interest Expense	2.27M	2.45M	2.05M	2.78M	3.36M
Imputed Operating Lease Depreciation	8.73M	10.55M	6.95M	8.22M	8.64M
Stock-Based Comp., Other (Total)	958M	979M	1.05B	1.14B	1.31B
Total Stock-Based Compensation	958M	979M	1.05B	1.14B	1.31B

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	9.66B	12.41B	7.52B	13.39B	11.46B
Short Term Investments	1.75B	15.82B	11.21B	680M	1.89B
Total Cash And Short Term Investments	11.4B	28.22B	18.73B	14.07B	13.35B
Accounts Receivable, Total	8.22B	8B	8.07B	7.11B	7.42B
Other Receivables	1.75B	1.56B	1.74B	2.14B	1.94B
Total Receivables	9.96B	9.56B	9.8B	9.25B	9.36B
Inventory	7.13B	6.67B	7.18B	5.91B	5.72B
Prepaid Expenses	943M	1.1B	911M	764M	985M
Other Current Assets, Total	232M	163M	297M	484M	283M
Total Current Assets	29.67B	45.72B	36.91B	30.48B	29.7B
Gross Property Plant And Equipment	29.89B	28.71B	26.3B	22.8B	21.97B
Accumulated Depreciation	-15.96B	-15.6B	-14.11B	-11.88B	-11.1B
Net Property Plant And Equipment	13.94B	13.11B	12.2B	10.92B	10.87B
Long-term Investments	11.61B	2.27B	1.61B	1.83B	1.13B
Goodwill	30B	29.6B	29.3B	23.34B	24.76B
Other Intangibles, Total	32.11B	28.68B	27.22B	21.55B	26.92B
Accounts Receivable Long-Term	83M	70M	59M	104M	54M
Loans Receivable Long-Term	89M	78M	85M	114M	102M
Deferred Tax Assets Long-Term	8.21B	3.74B	3.74B	4.31B	4.36B
Deferred Charges Long-Term	4.7B	5.5B	4.42B	5.33B	-
Other Long-Term Assets, Total	1.64B	3.04B	1.91B	1.97B	4.36B
Total Assets	132B	132B	117B	99.94B	102B
Liabilities
Accounts Payable, Total	5.4B	5.55B	5.15B	4.93B	4.57B
Accrued Expenses, Total	5.5B	5.15B	5.39B	5.17B	5.25B
Short-term Borrowings	7.32B	3.61B	3.64B	3.89B	4.73B
Current Portion of Long-Term Debt	2.47B	2.69B	2.3B	2.28B	3.5B
Current Portion of Leases	286M	275M	251M	230M	235M
Current Income Taxes Payable	2.46B	2.42B	2.53B	1.89B	1.6B
Unearned Revenue Current, Total	56M	123M	123M	98M	127M
Other Current Liabilities	9.57B	10.4B	9.28B	7.89B	8.68B
Total Current Liabilities	33.06B	30.21B	28.66B	26.39B	28.69B
Long-Term Debt	26.26B	22.9B	20.24B	18.44B	21.37B
Long-Term Leases	1.72B	1.62B	1.54B	1.6B	1.57B
Pension & Other Post Retirement Benefits	4.72B	3.79B	2.64B	2.73B	2.47B
Deferred Tax Liability Non Current	7.42B	3.07B	2.69B	2.25B	2.42B
Other Non Current Liabilities	2.22B	2.38B	2.27B	1.79B	1.6B
Total Liabilities	75.39B	63.97B	58.03B	53.2B	58.12B
Common Stock, Total	913M	901M	890M	825M	793M
Retained Earnings	57.16B	70.99B	63.54B	49.65B	46.56B
Treasury Stock	-53M	-48M	-92M	-41M	-53M
Comprehensive Income and Other	-1.42B	-4.19B	-5B	-3.77B	-3.26B
Total Common Equity	56.6B	67.66B	59.34B	46.67B	44.05B
Minority Interest	68M	167M	81M	83M	80M
Total Equity	56.67B	67.82B	59.42B	46.75B	44.13B
Total Liabilities And Equity	132B	132B	117B	99.94B	102B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.26B	2.23B	2.12B	2.04B	1.98B
ECS Total Common Shares Outstanding	2.26B	2.23B	2.12B	2.04B	1.98B
Book Value / Share	25.08	30.27	28	22.83	22.3
Tangible Book Value	-5.51B	9.38B	2.82B	1.78B	-7.62B
Tangible Book Value Per Share	-2.44	4.2	1.33	0.87	-3.86
Total Debt	38.05B	31.09B	27.96B	26.44B	31.4B
Net Debt	26.64B	2.87B	9.24B	12.37B	18.05B
Debt Equivalent of Unfunded Proj. Benefit Obligation	3.28B	1.16B	-1.41B	-897M	-1.09B
Debt Equivalent Oper. Leases	88M	104M	72M	88M	96M
Minority Interest, Total (Incl. Fin. Div)	68M	167M	81M	83M	80M
Equity Method Investments, Total	9.63B	205M	143M	205M	119M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	967M	870M	934M	963M	843M
Inventories - Work In Process, Total	3.32B	3.16B	3.67B	3.5B	3.45B
Inventories - Finished Goods, Total	2.84B	2.64B	2.57B	1.45B	1.43B
Land - (BS)	555M	492M	451M	403M	376M
Buildings, Total	12.38B	11.82B	11.4B	10.15B	9.53B
Machinery, Total	14.04B	13.33B	11.84B	9.63B	9.05B
Full Time Employees	106K	104K	102K	76.06K	75.88K
Accumulated Allowance for Doubtful Accounts (Supple)	93M	83M	62M	51M	58M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	8.07B	24.02B	6.96B	14.85B	11.94B
Depreciation & Amortization - CF	2.09B	1.53B	1.47B	1.18B	1.14B
Amortization of Goodwill and Intangible Assets - (CF)	3.46B	3.9B	3.98B	3.96B	3.46B
Depreciation & Amortization, Total	5.55B	5.43B	5.45B	5.14B	4.6B
(Gain) Loss From Sale Of Asset	-478M	-677M	-333M	-180M	-74M
(Gain) Loss on Sale of Investments - (CF)	-335M	-38M	260M	106M	45M
Asset Writedown & Restructuring Costs	914M	684M	1.73B	3.14B	1.47B
(Income) Loss On Equity Investments - (CF)	-673M	-15.34B	9M	15M	38M
Stock-Based Compensation (CF)	738M	736M	823M	865M	1.04B
Net Cash From Discontinued Operations	-	-	-	238M	-
Other Operating Activities, Total	2.59B	1.13B	1.23B	-7.81B	369M
Change In Accounts Receivable	137M	-389M	-589M	-1.5B	-931M
Change In Inventories	-543M	81M	-830M	-546M	-225M
Change In Accounts Payable	-324M	-21M	-48M	479M	-105M
Change in Other Net Operating Assets	-2B	-549M	-421M	-332M	-552M
Cash from Operations	13.65B	15.07B	14.24B	14.46B	17.62B
Capital Expenditure	-1.28B	-1.38B	-1.2B	-1.06B	-1.37B
Sale of Property, Plant, and Equipment	88M	240M	167M	237M	86M
Cash Acquisitions	-10.01B	-633M	-864M	-3.56B	-4.02B
Divestitures	49M	66M	-15M	3M	107M
Sale (Purchase) of Intangible assets	-930M	-845M	-1.27B	262M	-2.37B
Investment in Marketable and Equity Securities, Total	-922M	6.82B	4.65B	10.84B	43M
Other Investing Activities, Total	-186M	-57M	-1M	-1.12B	3M
Cash from Investing	-13.18B	4.21B	1.47B	5.6B	-7.51B
Short Term Debt Issued, Total	2.26B	-	295M	546M	958M
Long-Term Debt Issued, Total	7.13B	16M	16M	-	6.14B
Total Debt Issued	9.39B	16M	311M	546M	7.1B
Short Term Debt Repaid, Total	-	-3.52B	-	-	-289M
Long-Term Debt Repaid, Total	-2.32B	-2.48B	-2.87B	-2.48B	-2.42B
Total Debt Repaid	-2.32B	-6B	-2.87B	-2.48B	-2.71B
Issuance of Common Stock	748M	53M	100M	153M	30M
Repurchase of Common Stock	-2.84B	-3.06B	-10.65B	-8.72B	-8.33B
Common Dividends Paid	-6.99B	-7.37B	-7.51B	-7.26B	-7.62B
Common & Preferred Stock Dividends Paid	-6.99B	-7.37B	-7.51B	-7.26B	-7.62B
Other Financing Activities, Total	-199M	94M	55M	3.48B	-207M
Cash from Financing	-2.21B	-16.26B	-20.56B	-14.28B	-11.74B
Foreign Exchange Rate Adjustments	286M	-266M	-32M	100M	-298M
Net Change in Cash	-1.45B	2.75B	-4.89B	5.88B	-1.93B
Supplemental Items
Cash Interest Paid	703M	664M	696M	751M	855M
Cash Income Tax Paid (Refund)	1.83B	2.34B	1.98B	2.79B	2.26B
Levered Free Cash Flow	13.27B	13.12B	9.69B	12.13B	12.04B
Unlevered Free Cash Flow	13.81B	13.62B	10.21B	12.67B	12.67B
Change In Net Working Capital	-1.89B	-1.42B	1.85B	713M	-295M
Net Debt Issued / Repaid	7.07B	-5.99B	-2.56B	-1.94B	4.39B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	6.08	6.18	6.45	7.27	10.09
Return on Total Capital	8.48	8.28	8.63	9.84	13.72
Return On Equity %	14.38	38.59	10.93	16.15	26.28
Return on Common Equity	14.4	38.66	10.95	16.16	26.33
Margin Analysis
Gross Profit Margin %	71.14	70.81	70.9	74.24	75.22
SG&A Margin	28.24	28.02	27.38	26.77	24.29
EBITDA Margin %	34.89	33.92	34.74	37.54	39.95
EBITA Margin %	31.36	31.63	32.49	35.58	38.24
EBIT Margin %	24.42	24.25	24.81	27.09	31.55
Income From Continuing Operations Margin %	16.17	45.42	13.42	18.37	23.08
Net Income Margin %	16.18	45.43	13.42	31.83	23.09
Net Avail. For Common Margin %	16.18	45.43	13.42	18.36	23.09
Normalized Net Income Margin	14.93	32.16	14.66	16.32	18.91
Levered Free Cash Flow Margin	26.59	24.81	18.69	26	23.27
Unlevered Free Cash Flow Margin	27.68	25.77	19.7	27.15	24.49
Asset Turnover
Asset Turnover	0.4	0.41	0.42	0.43	0.51
Fixed Assets Turnover	3.6	3.91	4.1	4.04	4.75
Receivables Turnover (Average Receivables)	5.89	6.36	6.29	5.99	6.93
Inventory Turnover (Average Inventory)	2.2	2.24	2.18	1.84	2.2
Short Term Liquidity
Current Ratio	0.9	1.51	1.29	1.16	1.04
Quick Ratio	0.65	1.25	1	0.88	0.79
Operating Cash Flow to Current Liabilities	0.41	0.5	0.5	0.55	0.61
Days Sales Outstanding (Average Receivables)	62.12	57.35	58.03	60.94	52.84
Days Outstanding Inventory (Average Inventory)	166.64	163.13	167.46	198.72	166.16
Average Days Payable Outstanding	127.43	133.56	125.22	170.86	137.67
Cash Conversion Cycle (Average Days)	101.34	86.91	100.27	88.79	81.33
Long Term Solvency
Total Debt/Equity	67.15	45.84	47.06	56.55	71.16
Total Debt / Total Capital	40.17	31.43	32	36.12	41.58
LT Debt/Equity	49.37	36.16	36.66	42.85	51.97
Long-Term Debt / Total Capital	29.54	24.79	24.93	27.37	30.37
Total Liabilities / Total Assets	57.09	48.54	49.41	53.22	56.84
EBIT / Interest Expense	14.02	15.81	15.36	14.79	16.22
EBITDA / Interest Expense	20.41	22.51	21.87	20.79	20.79
(EBITDA - Capex) / Interest Expense	18.94	20.81	20.44	19.55	19.44
Total Debt / EBITDA	2.15	1.7	1.53	1.49	1.5
Net Debt / EBITDA	1.5	0.16	0.5	0.7	0.86
Total Debt / (EBITDA - Capex)	2.31	1.84	1.63	1.58	1.61
Net Debt / (EBITDA - Capex)	1.62	0.17	0.54	0.74	0.92
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.51	5.97	-1.98	7.36	10.85
Gross Profit, 1 Yr. Growth %	2.16	5.48	-1.86	7.7	12.32
EBITDA, 1 Yr. Growth %	10.17	5.71	0.38	9.93	17.95
EBITA, 1 Yr. Growth %	9.79	6.89	0.68	10.91	19.12
EBIT, 1 Yr. Growth %	6.74	5.23	0.27	12.78	29.09
Earnings From Cont. Operations, 1 Yr. Growth %	12.93	197.58	-71.04	41.71	39.28
Net Income, 1 Yr. Growth %	-31.2	197.58	-71.05	113.52	-19.59
Normalized Net Income, 1 Yr. Growth %	5.73	128.24	-55.51	15.19	28.45
Diluted EPS Before Extra, 1 Yr. Growth %	14.29	201.99	-70.18	48.55	43.17
Accounts Receivable, 1 Yr. Growth %	-1.01	-2.58	0.76	-11.89	4.45
Inventory, 1 Yr. Growth %	19.21	-6.52	7.64	-17.59	-3.21
Net Property, Plant and Equip., 1 Yr. Growth %	1.4	-5.98	-6.95	-10.42	-0.47
Total Assets, 1 Yr. Growth %	11.56	3.14	-10.88	-14.91	2.3
Tangible Book Value, 1 Yr. Growth %	-198.62	-270.18	-69.95	-36.98	114.61
Common Equity, 1 Yr. Growth %	2.03	19.54	-12.29	-21.36	-5.62
Cash From Operations, 1 Yr. Growth %	0.18	10.41	-5.54	1.56	21.86
Capital Expenditures, 1 Yr. Growth %	-7.54	8.08	-13.06	15.72	28.87
Levered Free Cash Flow, 1 Yr. Growth %	-3.16	2.26	-26.16	41.76	-0.78
Unlevered Free Cash Flow, 1 Yr. Growth %	-2.96	1.89	-25.07	39.84	-0
Dividend Per Share, 1 Yr. Growth %	8.97	-0.02	1.77	13.24	-1.44
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	4.04	4.22	1.92	3.01	9.09
Gross Profit, 2 Yr. CAGR %	6.01	4.55	2.79	3.11	10.47
EBITDA, 2 Yr. CAGR %	10.97	16.27	9.81	5.86	21.75
EBITA, 2 Yr. CAGR %	12.56	18.45	11.22	6.53	23.47
EBIT, 2 Yr. CAGR %	16.86	18.8	12.55	7.38	33.09
Earnings From Cont. Operations, 2 Yr. CAGR %	-20.59	83.32	-7.17	-38.82	40.49
Net Income, 2 Yr. CAGR %	-20	43.09	-7.18	-21.37	31.03
Normalized Net Income, 2 Yr. CAGR %	-9.68	74.52	10.91	-30.86	35.05
Diluted EPS Before Extra, 2 Yr. CAGR %	-19.71	85.78	-5.1	-36.41	45.84
Accounts Receivable, 2 Yr. CAGR %	-2.97	-1.8	-0.92	-5.78	-4.07
Inventory, 2 Yr. CAGR %	1.25	5.56	0.31	-5.82	-10.69
Net Property, Plant and Equip., 2 Yr. CAGR %	-5.76	-2.36	-6.46	-8.7	-5.58
Total Assets, 2 Yr. CAGR %	-4.75	5.52	-4.13	-12.92	-6.7
Tangible Book Value, 2 Yr. CAGR %	-47.04	29.55	-28.49	-56.48	64.49
Common Equity, 2 Yr. CAGR %	-15.15	10.43	2.4	-16.95	-13.85
Cash From Operations, 2 Yr. CAGR %	-2.2	5.17	2.12	-2.05	11.25
Capital Expenditures, 2 Yr. CAGR %	0.83	-0.04	-3.07	-0.28	22.12
Levered Free Cash Flow, 2 Yr. CAGR %	14.29	4.37	-8.45	1.51	28.32
Unlevered Free Cash Flow, 2 Yr. CAGR %	13.4	4.09	-8.14	1.62	27.34
Dividend Per Share, 2 Yr. CAGR %	9.42	4.24	1.03	7.35	5.64
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	4.76	4.68	2.11	-2.21	5.56
Gross Profit, 3 Yr. CAGR %	5.78	5.83	2.37	-0.13	6.09
EBITDA, 3 Yr. CAGR %	10.59	8.26	10.71	5.47	9.74
EBITA, 3 Yr. CAGR %	10.6	10.64	12.2	6.84	10.58
EBIT, 3 Yr. CAGR %	10.86	12.85	12.27	7.59	14.18
Earnings From Cont. Operations, 3 Yr. CAGR %	2.48	23.34	-0.9	2.03	-19.52
Net Income, 3 Yr. CAGR %	1.57	23.96	-15.99	22.53	-20.78
Normalized Net Income, 3 Yr. CAGR %	8.45	23.02	10.81	7.24	-15.01
Diluted EPS Before Extra, 3 Yr. CAGR %	3.55	24.87	0.96	5.22	-16.66
Accounts Receivable, 3 Yr. CAGR %	-1.51	-2.84	-0.95	-4.72	-2.48
Inventory, 3 Yr. CAGR %	1.27	-1.41	6.25	-6.05	-4.96
Net Property, Plant and Equip., 3 Yr. CAGR %	-5.4	-5.83	-3.91	-7.8	-6.04
Total Assets, 3 Yr. CAGR %	-0.26	-3.26	-0.26	-7.86	-8.11
Tangible Book Value, 3 Yr. CAGR %	-32.24	-21.85	-20.4	-31.44	-6.66
Common Equity, 3 Yr. CAGR %	-8.62	-4.88	2.27	-6.23	-13.33
Cash From Operations, 3 Yr. CAGR %	2.65	1.83	1.47	1.94	5.34
Capital Expenditures, 3 Yr. CAGR %	-1.27	3.19	-4.58	-5.97	8.62
Levered Free Cash Flow, 3 Yr. CAGR %	15.25	8.9	-7	1.63	0.74
Unlevered Free Cash Flow, 3 Yr. CAGR %	14.77	8.25	-6.71	1.54	1.08
Dividend Per Share, 3 Yr. CAGR %	4.96	6.08	3.51	4.94	4.34
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.19	1.38	3.61	0.24	1.22
Gross Profit, 5 Yr. CAGR %	1.48	3.16	4.15	1.86	2.58
EBITDA, 5 Yr. CAGR %	4.15	4.43	6.94	4.38	9.26
EBITA, 5 Yr. CAGR %	4.21	5.26	7.8	6.09	10.65
EBIT, 5 Yr. CAGR %	6.3	7.13	7.53	7.21	12.43
Earnings From Cont. Operations, 5 Yr. CAGR %	2.81	29.1	-1.49	-7.71	10.81
Net Income, 5 Yr. CAGR %	-14.61	29.05	-2.02	3.32	0.35
Normalized Net Income, 5 Yr. CAGR %	7.78	24.74	5.4	-3.57	11.87
Diluted EPS Before Extra, 5 Yr. CAGR %	4.1	30.58	0	-5.57	13.77
Accounts Receivable, 5 Yr. CAGR %	0.09	-0.49	-1.27	-4.02	-2.21
Inventory, 5 Yr. CAGR %	2.75	1.28	0.88	-3.2	-0.88
Net Property, Plant and Equip., 5 Yr. CAGR %	-2.7	-3.47	-5.83	-6.99	-4.58
Total Assets, 5 Yr. CAGR %	0.08	0.26	-2.47	-7.24	-2.89
Tangible Book Value, 5 Yr. CAGR %	-18.29	-10.98	-30.76	-38.17	6.42
Common Equity, 5 Yr. CAGR %	-5.98	-2	-4.36	-9.9	-4.51
Cash From Operations, 5 Yr. CAGR %	2.79	5.6	2.44	0.26	5.28
Capital Expenditures, 5 Yr. CAGR %	-11.64	-5.84	-2	-3.31	-0.19
Levered Free Cash Flow, 5 Yr. CAGR %	0.88	11.08	2.25	3.62	-0.01
Unlevered Free Cash Flow, 5 Yr. CAGR %	1.05	10.69	2.25	3.36	0.15
Dividend Per Share, 5 Yr. CAGR %	4.74	4.5	3.31	6.65	4.36